Package 68788-7866-6

{"route": ["ORAL"], "spl_id": "549f1700-86c6-4e21-9391-08de6ef3cbf2", "openfda": {"nui": ["N0000175753", "N0000008486"], "unii": ["VZI5B1W380"], "rxcui": ["312138"], "spl_set_id": ["e156339c-f79e-4a20-b9da-f50bea948213"], "pharm_class_pe": ["Decreased Central Nervous System Disorganized Electrical Activity [PE]"], "pharm_class_epc": ["Anti-epileptic Agent [EPC]"], "manufacturer_name": ["Preferred Pharmaceuticals Inc."]}, "finished": true, "packaging": [{"sample": false, "description": "30 TABLET, FILM COATED in 1 BOTTLE (68788-7866-3)", "package_ndc": "68788-7866-3", "marketing_start_date": "20210215"}, {"sample": false, "description": "60 TABLET, FILM COATED in 1 BOTTLE (68788-7866-6)", "package_ndc": "68788-7866-6", "marketing_start_date": "20210215"}, {"sample": false, "description": "90 TABLET, FILM COATED in 1 BOTTLE (68788-7866-9)", "package_ndc": "68788-7866-9", "marketing_start_date": "20210215"}], "brand_name": "OXCARBAZEPINE", "product_id": "68788-7866_549f1700-86c6-4e21-9391-08de6ef3cbf2", "dosage_form": "TABLET, FILM COATED", "pharm_class": ["Anti-epileptic Agent [EPC]", "Decreased Central Nervous System Disorganized Electrical Activity [PE]"], "product_ndc": "68788-7866", "generic_name": "OXCARBAZEPINE", "labeler_name": "Preferred Pharmaceuticals Inc.", "product_type": "HUMAN PRESCRIPTION DRUG", "brand_name_base": "OXCARBAZEPINE", "active_ingredients": [{"name": "OXCARBAZEPINE", "strength": "600 mg/1"}], "application_number": "ANDA078069", "marketing_category": "ANDA", "marketing_start_date": "20210215", "listing_expiration_date": "20261231"}